Monday 21 July 2014

Growth Hormone Analog Could Reduce the Risk of Fatty Liver Disease in HIV-infected Patients

Modest reduction in liver fat was seen in HIV patients having excess abdominal fat after they received a growth hormone releasing hormone analog for six months, a new study has found. Patients infected with HIV demonstrate a high prevalence of nonalcoholic fatty liver disease, estimated at 30 percent to 40 percent. The issue is being released early to coincide with the International AIDS Conference. In human immunodeficiency virus (HIV) infection, abdominal fat ...

via Medindia Health News More READ

No comments:

Post a Comment